Last reviewed · How we verify
Early Resumption of Oral Anticoagulation Therapy
Early Resumption of Oral Anticoagulation Therapy is a Small molecule drug developed by Rahul Raj. It is currently in Phase 1 development.
At a glance
| Generic name | Early Resumption of Oral Anticoagulation Therapy |
|---|---|
| Sponsor | Rahul Raj |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Early Resumption of Oral Anticoagulation Therapy CI brief — competitive landscape report
- Early Resumption of Oral Anticoagulation Therapy updates RSS · CI watch RSS
- Rahul Raj portfolio CI
Frequently asked questions about Early Resumption of Oral Anticoagulation Therapy
What is Early Resumption of Oral Anticoagulation Therapy?
Early Resumption of Oral Anticoagulation Therapy is a Small molecule drug developed by Rahul Raj.
Who makes Early Resumption of Oral Anticoagulation Therapy?
Early Resumption of Oral Anticoagulation Therapy is developed by Rahul Raj (see full Rahul Raj pipeline at /company/rahul-raj).
What development phase is Early Resumption of Oral Anticoagulation Therapy in?
Early Resumption of Oral Anticoagulation Therapy is in Phase 1.